Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00354692 · ClinicalTrials.gov registry record · Phase 4
Effect of Two Iron Preparations on Protein in the Urine
A Phase 4 study, sponsored by Watson Pharmaceuticals.
- Completed
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00354692 is a Phase 4 study that has completed, run by Watson Pharmaceuticals. The registered enrollment target is 12 participants.
The verdict
NCT00354692, a Phase 4 study, has completed, sponsored by Watson Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
Interventions
- DRUG Sodium Ferric Gluconate and Iron sucrose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00354692
The ClinicalTrials.gov registry entry for NCT00354692 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Watson Pharmaceuticals, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sodium Ferric Gluconate and Iron sucrose is the first listed.
NCT00354692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00354692 about?
NCT00354692 is a clinical study titled "Effect of Two Iron Preparations on Protein in the Urine". This pilot study will compare the effects of sodium ferric gluconate complex and iron sucrose on urine concentrations of various chemicals including protein
What is the current status of trial NCT00354692?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2006-06.
What interventions are being tested in trial NCT00354692?
The interventions under investigation include: Sodium Ferric Gluconate and Iron sucrose (DRUG).
Who is sponsoring clinical trial NCT00354692?
This trial is sponsored by Watson Pharmaceuticals, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.